Shares of Corbus Pharmaceuticals Holdings Inc. CRBP,
rose 10.88% to $ 3.42 on Wednesday in what turned out to be a mixed stock trading session with the Dow Jones Industrial Average DJIA,
increasing by 0.20% to 31,437.80 and the NASDAQ COMP composite index,
decreasing by 0.25% to 13,972.53. This was the third consecutive day of earnings of the share. Corbus Pharmaceuticals Holdings Inc. closed at $ 6.37 below the 52-week high ($ 9.78), which the company reached on August 31.
The action surpassed some of its competitors on Wednesday, such as Fate Therapeutics Inc. FATE,
fell 1.91% to $ 103.31, Vanda Pharmaceuticals Inc. VNDA,
fell 0.58% to $ 15.41, and Viking Therapeutics Inc. VKTX,
fell 2.09% to $ 8.89. The trading volume (66.0 M) overshadowed the 50-day average volume of 12.8 M.
Editor’s note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See the terms of use of our market data.